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Background: Patients with traumatic knee complaints regularly consult their general practitioner (GP). MRI might
be a valuable diagnostic tool to assist GPs in making appropriate treatment decisions and reducing costs. Therefore,
this study will assess the cost-effectiveness of referral to MRI by GPs compared with usual care, in patients with
persistent traumatic knee complaints.
Design and methods: This is a multi-centre, open-labelled randomised controlled non-inferiority trial in combination
with a concurrent observational cohort study. Eligible patients (aged 18–45 years) have knee complaints due to trauma
(or sudden onset) occurring in the preceding 6 months and consulting their GP. Participants are randomised to: 1) an
MRI group, i.e. GP referral to MRI, or 2) a usual care group, i.e. no MRI. Primary outcomes are knee-related daily function,
medical costs (healthcare use and productivity loss), and quality of life. Secondary outcomes are disability due to knee
complaints, severity of knee pain, and patients’ perceived recovery and satisfaction. Outcomes are measured at baseline
and at 1.5, 3, 6, 9 and 12 months follow-up. Also collected are data on patient demographics, GPs’ initial working
diagnosis, GPs’ preferred management at baseline, and MRI findings.
Discussion: In the Netherlands, the additional diagnostic value and cost-effectiveness of direct access to knee MRI
for patients presenting with traumatic knee complaints in general practice is unknown. Although GPs increasingly
refer patients to MRI, the Dutch clinical guideline ‘Traumatic knee complaints’ for GPs does not recommend referral
to MRI, mainly because the cost-effectiveness is still unknown.
Trial registration: Dutch Trial Registration: NTR3689.
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General practitioners (GPs) are often consulted by patients
with traumatic knee complaints. For musculoskeletal disor-
ders, knee complaints are the second most frequent reason
(after low back pain) for consulting the GP [1]. Traumatic
knee complaints are knee complaints due to a trauma of
the knee or are at least of a sudden onset, and therefore
likely to be traumatic. Traumatic knee complaints can be
caused by e.g. bone bruise, fracture, and/or soft tissue
injuries such as lesions of menisci, cruciate ligaments,
collateral ligaments and muscles [2-4]. In Dutch general
practice, the incidence and prevalence of knee complaints
are estimated at 20 and 30 per 1000 persons/year, respect-
ively, whereas the incidence and prevalence of traumatic
knee complaints are estimated at 5.3 and 6.8 per 1000
persons/year, respectively [1].
For the GP, diagnosing knee injuries other than fracture
or locked knee can be difficult [5-8]. Magnetic resonance
imaging (MRI) of the knee can help in establishing the
correct diagnosis or in excluding other diagnoses; this
additional knowledge can be used to decide on subsequent
treatment and/or referral of patients with traumatic knee
complaints. MRI is a powerful diagnostic tool for detecting
lesions of ligaments, tendons, bone, cartilage and menisci
[4,9,10]. MRI showed a sensitivity of 86%, 91%, 76%, a
specificity of 95%, 81%, 93% and an accuracy of 93%, 86%,
89% for anterior cruciate ligament, medial and lateral
meniscus lesions, respectively [9].
Recommendations for the diagnosis and management
of patients with traumatic knee complaints presenting in
primary care in the Netherlands are described in the
clinical guideline ‘Traumatic knee complaints’ issued
by the Dutch College of General Practitioners in 2010
[2]. At the GPs’ initial consultation an urgent referral
to a medical specialist is required when there are signs
of a fracture, acute locked knee, or severe complaints after
patella dislocation [2]. Otherwise, patients are managed
conservatively; this generally comprises information and
advice about the knee complaints, medication for pain
reduction and, if indicated, referral to physical therapy.
When complaints have not decreased at follow-up the
GP can refer the patient to an orthopaedic surgeon who
may request an MRI or perform an arthroscopy or surgery
[11]. In the Netherlands, at 1-year follow-up, 57% of
patients with traumatic knee complaints had consulted
their GP more than once, about one third was referred to
physical therapy, and 21% were referred to an orthopaedic
surgeon [12].
Direct referral to MRI might be a valuable tool for
GPs in making appropriate and informed decisions [13].
Negative MRI findings may enable the GP to reassure
patients, treat them conservatively, and avoid unnecessary
orthopaedic referrals. Positive MRI findings could con-
firm the GP’s diagnosis and the decision to either adviseconservative treatment or refer to an orthopaedic surgeon
in an earlier stage [14].
The DAMASK trial showed that an MRI referral by the
GP prior to a provisional orthopaedic appointment yielded
significant benefits in patients’ knee-related quality of life
when compared with direct referral to an orthopaedic
surgeon [15]. Another study showed that early MRI of the
knee in patients in secondary care with suspected internal
derangement facilitates faster diagnosis at a comparable
cost level compared with physical therapy; at 3-months
follow-up patients randomised for an early MRI reported
significantly less pain, less activity limitations and better
patient satisfaction [16].Aim
Whether MRI of the knee should enter the diagnostic
pathway in primary care, through direct access by GP’s,
depends on whether it improves patient outcomes, reduces
costs and affects subsequent diagnosis and management.
The objectives of this study over a period of 12 months
follow-up are:
1. To assess the cost-effectiveness of MRI referral by the
general practitioner compared to usual care in patients with
persistent traumatic knee complaints.
2. To assess if MRI referral by the general practitioner is
noninferior compared to usual care in patients with per-
sistent traumatic knee complaints regarding self-reported
knee related daily function.Methods
This study has been approved by the Medical Ethics
Committee of the Erasmus Medical Centre (Dutch Trial
Registration: NTR3689) [17].Design
The study will be a multi-centre, parallel group, open-
labelled, non-inferiority randomised controlled trial (RCT)
with a 1-year follow-up. Figure 1 presents a flow chart of
the study.
To assess the generalisability of the findings, patients
who are eligible but decline randomisation are invited to
participate in the concurrent observational cohort study; in
this latter study the inclusion criteria and measurements
are identical to those for the randomised patients. Inclusion
of these latter patients in an observational cohort will
provide insight into the potential selection of patients
entering the randomised cohort. Furthermore, it allows to
assess the course (e.g. medical consumption and outcomes)
of these non-randomised patients presenting with knee
complaints after a trauma within the participating general
practices, including the frequency of MRI referral and
referral to an orthopaedic surgeon.
Figure 1 Flow chart of the study.
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GPs located in the south west area of the Netherlands
will recruit eligible patients. The GP informs the patient
and sends contact data to the researchers. The researcher
contacts the patient by telephone and checks the inclusion/
exclusion criteria.
Patients are eligible for inclusion if they (re)consulted
their GP with knee complaints (knee pain and/or disability)
due to trauma or sudden onset in the preceding 6 months
and are aged 18–45 years. Patients are excluded if there is
an indication for direct referral to an orthopaedic surgeon(e.g. fracture, acute locked knee, or severe complaints after
patella dislocation).
Patients are also excluded when: 1) the knee complaints
are already managed in secondary care, 2) the patient is
known with osteoarthritis in the affected knee (diagnosis
confirmed by a medical specialist), 3) there is other non-
traumatic arthropathy (e.g. infection, Reiter’s syndrome,
gout, inflammatory bowel disease, or neuropathic pain) or
isolated patellofemoral joint pain, 4) there is a previous
MRI of the knee within the same episode of knee com-
plaints, 5) there is a previous surgical intervention of
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MRI (e.g. claustrophobia, metal implants or pregnancy).
Randomisation and interventions
When patients are eligible for inclusion and have com-
pleted the informed consent procedure, the baseline
measurement will take place. Hereafter, patients are ran-
domly allocated to the MRI or the usual care group. An
independent person produces a randomisation list by
computer, using random blocks of 4 and 6. Allocation by
one of the researchers (KvO or NS) will be concealed and
cannot be influenced or predicted because the randomisa-
tion list is not accessible to members of the research team.
MRI group
Patients will be referred for an MRI scan of the affected
knee at one of the participating MRI centres (in Rotterdam,
Amsterdam, Alkmaar, Goes, or Leiden) within 2 weeks after
referral. MRI is performed on a 1.5 T system using the
‘acute knee scanning protocol’; this is available in all par-
ticipating centres and is adjusted for the specific magnetic
resonance device. All protocols include imaging in the
coronal, sagittal and transversal plans, and all include a
T1 and a PD-weighted sequential, with or without fat
suppression. All participating musculoskeletal radiologists
(n = 12) have adequate experience working with these
predefined protocols.
In the Netherlands, there is no standardised way for a
radiologist to score and report MRI findings for pa-
tients with traumatic knee problems. For this reason, a
standardised and a digitalised report was developed for
the TACKLE Trial. This report was composed as an online
questionnaire, using an open source survey application
called the Lime Survey [18]. All radiologists are trained in
this standardised scoring of MRI features.
The following items are scored in the MRI report: the
quantity of synovial fluid and soft tissues, menisci, anterior
and posterior cruciate ligaments, medial and lateral collat-
eral tendons and the bone and cartilage. The report will
produce a treatment/referral advice for the GP based on
the latest consensus in the literature, expert opinion and
daily practice [11,19]. Table 1 presents an overview of the
most significant findings and the treatment/referral advice
for GPs.
The radiologist will report the details on possible path-
ology to the GP, together with a treatment/referral advice
(based on Table 1). In case of positive MRI findings, the
advice of the radiologist will be to refer to an orthopaedic
surgeon. The orthopaedic surgeon will decide whether
arthroscopy or surgery is required, based on clinical
findings and on the Dutch orthopaedic guidelines [11,19].
In case of negative MRI findings the advice of the radiolo-
gist will be to continue treatment in primary care according
to the Dutch clinical guideline ‘Traumatic knee complaints’(see Usual care group). In case of equivocal findings, based
on severity of the injury, the radiologist will decide whether
the advice will be to continue treatment in primary care
or to refer to an orthopaedic surgeon. Finally, the GP will
decide whether or not to refer the patient, based on the
radiologist’s report and the patient’s current complaints.
The inter-rater reliability of the radiologist’s advice was
determined for eight participating radiologists using 10
MRIs of patients with traumatic knee complaints. The
intra-class correlation coefficient was 0.65, reflecting
reasonable agreement.
Usual care group
These patients are treated according to the Dutch clinical
guideline ‘Traumatic knee complaints’, i.e. without MRI
[2]. When there are signs of contusion, distortion, medial
or lateral collateral ligament lesion, patients are advised to
continue their daily activities and load the knee as much
as possible. When there are indications of meniscal lesions
and/or cruciate ligament lesions, patients are advised to
take rest for a few days and to use elbow crutches if neces-
sary. When pain and effusion decreases patients are ad-
vised to flex and extend the knee without load bearing, to
do isometric muscle training of the quadriceps muscle,
and gradually increase their daily activities. For additional
support regarding exercises the GP can refer the patient
to a physical therapist. Follow-up consultations are planned
with an interval of (at most) 2 weeks.
Outcomes
Patients will fill in questionnaires at baseline and at 1.5, 3,
6, 9 and 12-months follow-up (Table 2). The questionnaires
are sent by e-mail which contains a secured hyperlink to
the questionnaire. For this purpose the survey application
the Lime Survey is used [18].
Primary outcomes
1) Patients’ knee-related daily function is measured with
the Lysholm Scale [20]. This scale is well documented
according to validity, reliability and responsiveness in
patients with traumatic knee injuries [21,22]. The
Lysholm Scale summarizes activity limitations and
symptoms related to activity. The score consists of 8
items rated on a 100-point scale, with instability and
pain being allocated 25 points each [20]. A higher
score indicates better knee function.
2) Medical costs are measured for the health care use
and productivity loss. Healthcare use is measured
with the Medical Consumption Questionnaire from
the Institute for Medical Technology Assessment
(iMCQ), adjusted to fit our population [23]. The
iMCQ includes questions related to frequently







Table 1 Types of findings on MRI and related advice
Positive findings (advice for referral to
orthopaedic surgeon)
Equivocal findings (advice based on
radiologist’s judgement)
Negative findings (advice for treatment
in primary care)
Pigmented villonodular synovitis Synovitis, bursitis, hoffitis, any other cyst Effusion, Baker’s cyst, ganglion, plica,
subcutaneous oedema
Lesions of the m. quadriceps tendon, the
patellar tendon or the patellar retinacula
Osteochondrosis dissecans fracture Lesions of the trochlea or patellar alignment
anomalies
Bone bruise or bone marrow oedema
Meniscal tears* Parameniscal cyst, meniscal extrusion,
discoid meniscus, isolated lesions of
meniscal ligaments or meniscal capsular
lesions
Partial or complete anterior or posterior
cruciate ligament tears
Mucoid degeneration of the cruciate
ligaments
Grade III injury (complete rupture) of the
medial collateral ligament or the
posterolateral corner
Grade I and II injury of the medial
collateral ligament or the posterolateral
corner
Grade IV chondromalacia Grade I to III chondromalacia
*A meniscal tear is defined as an abnormal shape of the meniscus OR as a high signal intensity unequivocally contacting the surface of the meniscus. The latter
must be seen on at least 2 adjacent slices in one plane.
Swart et al. BMC Musculoskeletal Disorders 2014, 15:63 Page 5 of 7
http://www.biomedcentral.com/1471-2474/15/63Healthcare costs are calculated by multiplying
healthcare use by Dutch standard prices [24].
Productivity loss is measured with the Productivity
Cost Questionnaire from the Institute for Medical
Technology Assessment (iPCQ) [25]. The iPCQ
consist of 12 items in three modules: lost productivity
at paid work due to absenteeism, lost productivity at
paid work due to presenteeism, and lost productivity
at unpaid work. Productivity costs are calculated by
multiplying productivity losses by standard Dutch age
and sex-specific prices per hour [24].
3) Patients’ quality of life is measured with the EuroQol
5-Dimensions (EQ-5D-3 L). The EQ-5D-3 L consists
of 6 items. Items 1–5 measure the health state on five
dimensions (mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression). Each dimension
has 3 levels: level 1 indicates no problems, level 2ble 2 Measurement of primary and secondary outcomes
Baseline 1.5 months 3 mo
imary
Lysholm X X X
iMCQ/iPCQ X – X
EQ-5D-3 L X X X
condary
KOOS X X X
NRS X X X
GPE X X X
Satisfaction X X X
sholm = Lysholm Scale. iMCQ=Medical Consumption Questionnaire from the Institu
m the Institute for Medical Technology Assessment. EQ-5D-3 L = EuroQol 5-Dimensi
ale. GPE = Global Perceived Effect.indicates some problems, and level 3 indicates
extreme problems. Item 6 measures the self-rated
health on a vertical visual analogue scale (VAS)
where the endpoints are labelled best imaginable
health state (100) and worst imaginable health state
(0). [26] There is evidence of construct validity and
reliability for patients with knee injuries [27].
Secondary outcomes
1) Disability due to knee complaints is assessed with
the Knee Injury and Osteoarthritis Outcome Score
(KOOS) [28]. This questionnaire consist of 42
questions for five dimensions (pain, symptoms,
function in daily living, function in sport and
recreation, and knee-related quality of life). The








te for Medical Technology Assessment. iPCQ= Productivity Cost Questionnaire
ons. KOOS = Knee Injury and Osteoarthritis Outcome Score. NRS = numeric rating
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subscale on a scale from 0–100, a higher score
indicating more symptoms. The KOOS has good
validity, reliability, responsiveness, internal
consistency and no floor or ceiling effect [28].
2) Severity of knee pain is assessed with the numeric
rating scale (NRS). The NRS is an 11-point Likert
scale, where 0 indicates no pain and 10 indicates
unbearable pain. The NRS is a valid, reliable and
appropriate rating scale for capturing severity of pain
in clinical practice [29].
3) Patients’ perceived recovery is assessed with the Global
Perceived Effect (GPE). The GPE is a 7-point Likert
scale ranging from completely recovered to worse than
ever [30]. The reliability of the GPE is excellent [31].
4) Patients’ satisfaction with the treatment is measured
on a 7-point Likert scale ranging from absolutely
satisfied to absolutely dissatisfied.
At baseline the following demographic data are collected:
age, gender, height, weight, education level, co-morbidity,
duration of complaints and previous knee complaints.
Also collected are data on GPs’ initial working diagnosis,
GPs’ preferred management at baseline, and MRI findings.
Sample size calculation
The sample size is based on the Lysholm Scale. In our
pilot study, at 1-year follow-up, the effect (Lysholm Scale)
of usual care in general practice was estimated at a mean
difference of −23 with a standard deviation of 17 (95%
confidence interval; CI −27.8; −18.2) [12]. To obtain 80%
statistical power with a 2-sided alpha of 0.05, 225 patients
per treatment group are required to establish the non-
inferiority of MRI referral by the GP compared with usual
care within 4.8 points on the Lysholm Scale. Hence, using a
2-sided alpha of 0.05 and 225 patients per group, the trial
has a 91% power to detect superiority of MRI referral over
usual care assuming a clinically relevant difference of 15%
in knee function. Based on previous studies we expect a
loss to follow-up of 15%; therefore, the planned trial will re-
quire 520 patients with traumatic knee complaints [12,14].
Statistical analysis
Success of the randomisation and distribution of outcome
measures will be checked before the actual analyses
are performed. The baseline characteristics of the non-
randomised patients in the cohort are analysed and
compared with those of the randomised patients to gain
insight into potential selection bias.
The economic evaluation is a cost-utility analysis from
the societal perspective (costs per quality adjusted life-year;
QALY), based on patients’ reports. A 1-year time horizon
will be used, without discounting. Costs related to out-
come are analysed using net-benefit acceptability curves,multiple imputation and bootstrapping, including only the
uncertainty due to trial sampling error. Cost price analyses
are performed for MRI and orthopaedic consultations.
Other costs are valued using standard prices (including
time involved and travel costs) [24]. QALYs are esti-
mated as the area under the observed 1-year utility
curves. Utilities are estimated using the EQ-5D-3 L
(primary analysis, Dutch tariff ) and the patients’ health
VAS, transformed to a utility scale using the power
transformation U = 1-(1-VAS/100)1.61.
We will evaluate whether MRI referral by GPs is
non-inferior compared with usual care in accordance with
the clinical guideline, beyond a specified non-inferiority
margin (delta) with a defined confidence interval. Non-
inferiority of MRI over usual care will be accepted if
the upper bound of the 95% CI around the estimated
difference in primary outcome (Lysholm Scale) lies
below delta. A delta of 4.8 is adopted; this is based on the
expected effect in the usual care group as found in our
pilot study (see Sample size calculation), and on judge-
ment about the difference between treatments that would
be clinically meaningful.
The outcome of both groups are analysed on the basis
of the ‘intention to treat’ principle. Linear mixed models
with repeated measurements are used to calculate group
differences over time. We will adjust for baseline variables
that have a clinically meaningful difference between the
two groups. In non-inferiority trials, because an intention
to treat analysis can increase the type I error (i.e. the risk
of falsely claiming non-inferiority), we will also perform a
per-protocol analysis [32].
Additionally, we will perform exploratory analysis to
identify clinical indicators for better (cost) effectiveness
over a 1-year period using univariable and multivariate
logistic regression analysis. Different usual thresholds (i.e.
16, 20 and 40 thousand euros per QALY) for the maximum
willingness to pay for an extra QALY will be explored.
Discussion
Although GPs in the Netherlands increasingly refer
patients with knee complaints to MRI, there is lack of evi-
dence regarding whether or not this is cost-effective care.
We have reported the design of a non-inferior RCT to in-
vestigate the cost-effectiveness of MRI on referral of the
GP compared with usual care, in patients with traumatic
knee complaints.
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